{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_000345.4:c.137A>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "C",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "46"
          },
          "Description in input context": "E46A"
        },
        {
          "HGVS": "NM_000345.4:c.247G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "247"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "83"
          },
          "Description in input context": "E83K"
        },
        {
          "HGVS": "NM_000345.4:c.248A>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "C",
            "position": "248"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "83"
          },
          "Description in input context": "E83A"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD);Dementia with Lewy bodies (DLB)",
    "MONDO": "MONDO:0005180;MONDO:0007488"
  },
  "Experiment Method": [
    {
      "Assay Method": "Filament Assembly and Centrifugal Sedimentation",
      "Material used": {
        "Material Source": "Bacterial Expression System",
        "Material Name": "Escherichia coli BL21(DE3)",
        "Description": "Human α-synuclein cDNA was cloned into the bacterial expression vector pRK172 and expressed in Escherichia coli BL21(DE3)."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutation in α-synuclein increased the propensity of α-synuclein to fibrillize compared with the WT protein."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation in α-synuclein showed a greater increase in the propensity of α-synuclein to fibrillize than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "The E46A mutation in α-synuclein resulted in two types of mature fibrils, some with typical morphology and others resembling nonspecific protein aggregation."
        },
        {
          "Variant": "NM_000345.4:c.247G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutations at residue Glu83 (E83K) increased the ability of α-synuclein to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutations at residue Glu83 (E83A) resulted in filaments that were significantly narrower than the WT α-synuclein protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were performed with multiple biological samples to ensure reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Technical replicates were performed to ensure the reliability of the results."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type (WT) α-synuclein was used as the basic positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "K114 Fluorometry",
      "Material used": {
        "Material Source": "Bacterial Expression System",
        "Material Name": "Escherichia coli BL21(DE3)",
        "Description": "Human α-synuclein cDNA was cloned into the bacterial expression vector pRK172 and expressed in Escherichia coli BL21(DE3)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutant protein had a tendency to form compact bundles of fibrils."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutant protein showed a greater increase in amyloid fibril formation than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "The E46A mutant protein often formed amorphous, elongated polymers that had a very distinct morphology compared with typical α-synuclein filaments."
        },
        {
          "Variant": "NM_000345.4:c.247G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutations at residue Glu83 (E83K) yielded fibrils that were narrower than the WT α-synuclein protein."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutations at residue Glu83 (E83A) resulted in filaments that were significantly narrower than the WT α-synuclein protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were performed with multiple biological samples to ensure reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Technical replicates were performed to ensure the reliability of the results."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type (WT) α-synuclein was used as the basic positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Electron Microscopy (EM)",
      "Material used": {
        "Material Source": "Bacterial Expression System",
        "Material Name": "Escherichia coli BL21(DE3)",
        "Description": "Human α-synuclein cDNA was cloned into the bacterial expression vector pRK172 and expressed in Escherichia coli BL21(DE3)."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutant protein had a tendency to form compact bundles of fibrils."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutant protein showed a greater increase in amyloid fibril formation than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "The E46A mutant protein often formed amorphous, elongated polymers that had a very distinct morphology compared with typical α-synuclein filaments."
        },
        {
          "Variant": "NM_000345.4:c.247G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutations at residue Glu83 (E83K) yielded fibrils that were narrower than the WT α-synuclein protein."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Mutations at residue Glu83 (E83A) resulted in filaments that were significantly narrower than the WT α-synuclein protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were performed with multiple biological samples to ensure reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Technical replicates were performed to ensure the reliability of the results."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type (WT) α-synuclein was used as the basic positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Calpain I Cleavage of α-Syn Proteins",
      "Material used": {
        "Material Source": "Bacterial Expression System",
        "Material Name": "Escherichia coli BL21(DE3)",
        "Description": "Human α-synuclein cDNA was cloned into the bacterial expression vector pRK172 and expressed in Escherichia coli BL21(DE3)."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "The E46K mutation in α-synuclein resulted in a slight increase in the mobility of product #4 after calpain I cleavage."
        },
        {
          "Variant": "NM_000345.4:c.137A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "The E46A mutation in α-synuclein resulted in a slight increase in the mobility of product #4 after calpain I cleavage."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A53T mutation in α-synuclein significantly reduced cleavage at the major calpain I site."
        },
        {
          "Variant": "NM_000345.4:c.247G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were performed with multiple biological samples to ensure reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Technical replicates were performed to ensure the reliability of the results."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type (WT) α-synuclein was used as the basic positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}